tiprankstipranks
Trending News
More News >
Crescent Biopharma (CBIO)
NASDAQ:CBIO
US Market

Crescent Biopharma (CBIO) Cash flow

Compare
997 Followers

Crescent Biopharma Cash Flow

CBIO's free cash flow for Q3 2025 was $-18.11M. For the 2025 fiscal year, CBIO's free cash flow was decreased by $3.79M and operating cash flow was $-17.52M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -31.10M$ -34.88M$ -46.46M$ -57.49M$ -39.24M
Investing Cash Flow
$ 20.03K$ -21.39K$ -84.19K$ -14.94K$ -68.51K
Financing Cash Flow
$ 5.40K$ 28.82M$ 4.16M$ 10.72M$ 18.14M
End Cash Position
$ 10.72M$ 41.79M$ 47.87M$ 90.25M$ 137.04M
Free Cash Flow
$ -31.11M$ -34.90M$ -46.54M$ -57.50M$ -39.31M
Currency in USD

Crescent Biopharma Cash Flow